UNH Quote, Financials, Valuation and Earnings

Centene has a net margin of 6.11% compared to UnitedHealth Group's net margin of 1.7%. UnitedHealth Group's return on equity of 14.51% beat Centene's return on equity of 11.5%.

UnitedHealth Group has a consensus price target of $635.28, signalling upside risk potential of 23.67%. On the other hand Centene has an analysts' consensus of $79.39 which suggests that it could grow by 26.64%. Given that Centene has higher upside potential than UnitedHealth Group, analysts believe Centene is more attractive than UnitedHealth Group.

UnitedHealth Group has a beta of 0.617, which suggesting that the stock is 38.345% less volatile than S&P 500. In comparison Centene has a beta of 0.448, suggesting its less volatile than the S&P 500 by 55.17%.

UnitedHealth Group has a quarterly dividend of $2.10 per share corresponding to a yield of 1.59%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UnitedHealth Group pays 30.21% of its earnings as a dividend. Centene pays out -- of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

UnitedHealth Group quarterly revenues are $99.2B, which are larger than Centene quarterly revenues of $42B. UnitedHealth Group's net income of $6.1B is higher than Centene's net income of $713M. Notably, UnitedHealth Group's price-to-earnings ratio is 33.46x while Centene's PE ratio is 10.88x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UnitedHealth Group is 1.23x versus 0.21x for Centene. Usually stocks with elevated PS ratios are considered overvalued.

Elevance Health has a net margin of 6.11% compared to UnitedHealth Group's net margin of 2.25%. UnitedHealth Group's return on equity of 14.51% beat Elevance Health's return on equity of 15.67%.

UnitedHealth Group has a consensus price target of $635.28, signalling upside risk potential of 23.67%. On the other hand Elevance Health has an analysts' consensus of $503.34 which suggests that it could grow by 32.58%. Given that Elevance Health has higher upside potential than UnitedHealth Group, analysts believe Elevance Health is more attractive than UnitedHealth Group.

UnitedHealth Group has a beta of 0.617, which suggesting that the stock is 38.345% less volatile than S&P 500. In comparison Elevance Health has a beta of 0.840, suggesting its less volatile than the S&P 500 by 15.968%.

UnitedHealth Group has a quarterly dividend of $2.10 per share corresponding to a yield of 1.59%. Elevance Health offers a yield of 1.72% to investors and pays a quarterly dividend of $1.63 per share. UnitedHealth Group pays 30.21% of its earnings as a dividend. Elevance Health pays out 23.3% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

UnitedHealth Group quarterly revenues are $99.2B, which are larger than Elevance Health quarterly revenues of $45.1B. UnitedHealth Group's net income of $6.1B is higher than Elevance Health's net income of $1B. Notably, UnitedHealth Group's price-to-earnings ratio is 33.46x while Elevance Health's PE ratio is 13.84x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UnitedHealth Group is 1.23x versus 0.51x for Elevance Health. Usually stocks with elevated PS ratios are considered overvalued.

Molina Healthcare has a net margin of 6.11% compared to UnitedHealth Group's net margin of 3.15%. UnitedHealth Group's return on equity of 14.51% beat Molina Healthcare's return on equity of 25.77%.

UnitedHealth Group has a consensus price target of $635.28, signalling upside risk potential of 23.67%. On the other hand Molina Healthcare has an analysts' consensus of $358.46 which suggests that it could grow by 20.16%. Given that UnitedHealth Group has higher upside potential than Molina Healthcare, analysts believe UnitedHealth Group is more attractive than Molina Healthcare.

UnitedHealth Group has a beta of 0.617, which suggesting that the stock is 38.345% less volatile than S&P 500. In comparison Molina Healthcare has a beta of 0.543, suggesting its less volatile than the S&P 500 by 45.712%.

UnitedHealth Group has a quarterly dividend of $2.10 per share corresponding to a yield of 1.59%. Molina Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UnitedHealth Group pays 30.21% of its earnings as a dividend. Molina Healthcare pays out -- of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

UnitedHealth Group quarterly revenues are $99.2B, which are larger than Molina Healthcare quarterly revenues of $10.3B. UnitedHealth Group's net income of $6.1B is higher than Molina Healthcare's net income of $326M. Notably, UnitedHealth Group's price-to-earnings ratio is 33.46x while Molina Healthcare's PE ratio is 15.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UnitedHealth Group is 1.23x versus 0.44x for Molina Healthcare. Usually stocks with elevated PS ratios are considered overvalued.

Oscar Health has a net margin of 6.11% compared to UnitedHealth Group's net margin of -2.25%. UnitedHealth Group's return on equity of 14.51% beat Oscar Health's return on equity of 2.86%.

UnitedHealth Group has a consensus price target of $635.28, signalling upside risk potential of 23.67%. On the other hand Oscar Health has an analysts' consensus of $19.36 which suggests that it could grow by 31.5%. Given that Oscar Health has higher upside potential than UnitedHealth Group, analysts believe Oscar Health is more attractive than UnitedHealth Group.

UnitedHealth Group has a beta of 0.617, which suggesting that the stock is 38.345% less volatile than S&P 500. In comparison Oscar Health has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

UnitedHealth Group has a quarterly dividend of $2.10 per share corresponding to a yield of 1.59%. Oscar Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UnitedHealth Group pays 30.21% of its earnings as a dividend. Oscar Health pays out -- of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

UnitedHealth Group quarterly revenues are $99.2B, which are larger than Oscar Health quarterly revenues of $2.4B. UnitedHealth Group's net income of $6.1B is higher than Oscar Health's net income of -$54.6M. Notably, UnitedHealth Group's price-to-earnings ratio is 33.46x while Oscar Health's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UnitedHealth Group is 1.23x versus 0.48x for Oscar Health. Usually stocks with elevated PS ratios are considered overvalued.